Previous Article | Next Article 
Infection and Immunity, October 2001, p. 6044-6054, Vol. 69, No. 10
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6044-6054.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Molecular Cloning of a Bacteroides caccae
TonB-Linked Outer Membrane Protein Identified by an Inflammatory
Bowel Disease Marker Antibody
Bo
Wei,1
Harnisha
Dalwadi,1
Lynn K.
Gordon,2
Carol
Landers,3
David
Bruckner,1
Stephan R.
Targan,3,4 and
Jonathan
Braun1,5,*
Departments of Pathology and Laboratory
Medicine,1
Ophthalmology,2 and
Medicine4 and Molecular Biology
Institute,5 University of California, Los
Angeles, California 90095, and Inflammatory Bowel Disease
Research Center, Cedars-Sinai Medical Center, Los Angeles, California
900483
Received 13 October 2000/Returned for modification 7 December
2000/Accepted 10 July 2001
 |
ABSTRACT |
Commensal enteric bacteria are a required pathogenic factor in
inflammatory bowel disease (IBD), but the identity of the pertinent bacterial species is unresolved. Using an IBD-associated pANCA monoclonal antibody, a 100-kDa protein was recently characterized from
an IBD clinical isolate of Bacteroides caccae (p2Lc3).
In this study, consensus oligonucleotides were designed from 100-kDa peptides and used to identify a single-copy gene from the p2Lc3 genome.
Sequence analysis of the genomic clone revealed a 2,844-bp (948 amino
acid) open reading frame encoding features typical of the TonB-linked
outer membrane protein family. This gene, termed ompW,
was detected by Southern analysis only in B. caccae and was absent in other species of Bacteroides and
gram-negative coliforms. The closest homologues of OmpW included the
outer membrane proteins SusC of Bacteroides
thetaiotaomicron and RagA of Porphyromonas gingivalis. Recombinant OmpW protein was
immunoreactive with the monoclonal antibody, and serum
anti-OmpW immunoglobulin A levels were elevated in a Crohn's
disease patient subset. These findings suggest that OmpW may be a
target of the IBD-associated immune response and reveal its
structural relationship to a bacterial virulence factor of P.
gingivalis and periodontal disease.
 |
INTRODUCTION |
Human inflammatory bowel disease
(IBD) represents a set of a chronic, relapsing, and remitting
intestinal inflammatory disorders involving T-cell-mediated mucosal and
mural destruction and polygenic familial susceptibility (34,
35). Several spontaneous and transgenic mouse strains have been
established with susceptibility for chronic colitis similar to human
IBD (4, 5, 18, 20, 26, 32). In all evaluated models,
normal resident enteric bacteria were found to be required for
disease pathogenesis (13, 27, 40). Similarly, in human IBD
several lines of evidence implicate enteric bacteria as a pathogenic
factor in clinical disease, particularly in Crohn's disease (CD)
(3, 33, 48).
Immunologic studies have demonstrated that antibody and T-cell
reactivity to commensal enteric bacteria is a distinguishing feature of
colitic mouse strains (6, 10). However, the bacterial species and antigens recognized by colitigenic T cells have not yet
been defined. Moreover, monoassociation studies have not yet revealed
pathogenic bacterial species for colitis-prone mouse strains
(27). A systematic approach to this issue is hampered by
the limited understanding of gastrointestinal microflora ecosystem. In
addition, immune recognition of this commensal microflora in normal
individuals is attenuated or undetectable. Accordingly, it has been
difficult to highlight bacterial species or antigens for
evaluation in IBD pathogenesis.
Marker antibodies have been used successfully to identify
disease-relevant antigenic targets in several immune-mediated
diseases (38, 45). In IBD, approximately 60 to 70%
of ulcerative colitis (UC) patients and 25% of CD patients have
elevated levels of pANCA, an antineutrophil cytoplasmic antibody with
distinctive morphological and antigenic fine specificity (15, 30,
36, 41, 51). An immunochemical study has associated pANCA
with enteric bacterial antigens by serum cross-reactivity in
human and mouse (39). This observation provides a
precedent for the hypothesis that pANCA antibody would identify the
antigenic proteins responsible for the pathogenic mucosal inflammation.
We have addressed this hypothesis using two pANCA monoclonal antibodies
(Fab 5-3 and 5-2) to search for bacterial cross-reactive proteins
associated with the UC-specific immune response. These antibodies
were isolated by phage display technology from lamina propria
lymphocytes of UC patient. Their concordance with serum pANCAs was
validated by the criteria of immunofluorescence, confocal microscopy,
and DNase I sensitivity (17). To our knowledge, these are
the only reported pANCA monoclonal antibodies. Experience has
shown that antigen discovery with individual monoclonal
antibodies can be misleading and is best pursued with a diverse
monoclonal antibody panel. However, because of the unique disease
association of pANCA, we proceeded with the available monoclonal
antibodies in a bacterial antigen search.
Using Fab 5-3, we identified two candidate bacterial pANCA
antigens in a search of colonic bacterial clinical isolates from an IBD
patient: OmpC of Escherichia coli, and a novel 100-kDa protein of Bacteroides caccae (8). In the
present study, the gene encoding the 100-kDa protein is cloned and
characterized. We show that this protein is a new TonB-linked outer
membrane protein (termed OmpW) closely related to the RagA virulence
factor of Porphyromonas gingivalis. Immunologic assessment
demonstrated that immunoglobulin A (IgA) anti-OmpW is elevated in
a subset of CD patients. These finding suggest that B. caccae and OmpW may be bacterial targets of the disease-related
immune response in IBD.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
A panel of
Bacteroides clinical isolates (3955-3, 4536, 4552, 4556, 4562, 4570, 4578, and 4579) were stored and cultured in the clinical
laboratories at University of California, Los Angeles (UCLA). B. vulgatus strains LG-1, LG1-33, and CPT-6 were kind gifts from
R. B. Sartor, University of North Carolina at Chapel Hill.
B. caccae strains 43185 and p2Lc3 were from the American Type Culture Collection and a colonic isolate of a Crohn's disease patient (8), respectively. Clinical isolates of E. coli, Salmonella enterica serovar Typhi, and
Shigella flexneri were provided by UCLA Clinical
Laboratories. All Bacteroides strains were grown on brucella
blood agar in an anaerobic chamber with 10%
CO2-90% N2 atmosphere at
37°C.
Recombinant cloning reagents.
E. coli XL-1 Blue
strain (Stratagene, La Jolla, Calif.) was used for all cloning and
recombinant expression experiments. The pBluescript vector (Stratagene)
and pCR 2.1 plasmid (Invitrogen, Carlsbad, Calif.) vector were used for
cloning in E. coli XL-1 Blue and selected on Luria-Bertani
(LB) medium agar plate (1% tryptone, 0.5% yeast extract, 0.5% NaCl,
1.5% agar) supplemented with ampicillin (100 µg/ml). Blue or white
colony color selection was used to distinguish between nonrecombinant
and recombinant E. coli clones by spreading X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) and IPTG (isopropyl-
-D-thiogalactopyranoside)
on LB plates in the cloning procedures. All restriction enzymes used in
this study were purchased from New England Biolabs (Beverly, Mass.).
Human monoclonal anti-pANCA antibody (Fab 5-3) was used to analyze
recombinant OmpW protein (17). Alkaline
phosphatase-conjugated goat anti-human F(ab)2
(Pierce, Rockford, Ill.) was used as the secondary antibody in Western
blot analysis.
Construction and screening of genomic library.
Genomic
library of a B. caccae clinical isolate (p2Lc3) was
constructed using lambda ZAPII
phage vector (Stratagene, La Jolla,
Calif.). Briefly, chromosomal DNA was purified from p2Lc3 using the
ASAP genomic DNA isolation kit (Boehringer Mannheim, Indianapolis,
Ind.), partially digested with EcoRI, and fragments ranging
from 1.5 to 9 kb were ligated into lambda ZAPII
EcoRI-digested, calf intestinal alkaline phosphatase
(CIAP)-treated vector. Recombinant lambda phages were packaged, and the
PFU of packaging reaction (primary library) were titrated. The primary
library was plated at appropriate dilution on large 150-mm agar plates
to 5 × 104 PFU/plate and incubated at
37°C for 8 h. The phage plaques from each plate were transferred
onto duplicated Hybond-N membranes (Amersham Pharmacia Biotech,
Piscataway, N.J.), denatured in 0.5 N NaOH-1.5 M NaCl, and neutralized
in 0.5 M Tris-Cl-1.5 M NaCl (pH 8.0), rinsed in 0.2 M Tris-Cl-2× SSC
(1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) buffer solution,
and fixed using the Stratalinker UV cross-linker (Stratagene).
According to Bacteroides preferred codons, two
oligonucleotide probes were designed for the 100-kDa N-terminal
peptides DPSSLAIFGVR (Pep1) and GPSEADAFYNC (Pep2) and purchased from
Gibco-BRL (Rockville, Md.). The oligonucleotides were labeled with
32P by T4 polynucleotide kinase using DNA 5'-end
labeling kit (Boehringer Mannheim, Indianapolis, Ind.), and used to
screen p2Lc3 genomic libraries. The same probes were also used to
identify positive phagemids in Southern blot analysis.
The membranes were prehybridized in Rapid-Hyb buffer (Amersham
Pharmacia) for at least 1 h and then hybridized with a mixture
of
[
32P]Pep1 and [
32P]Pep2
probes in the same buffer for 6 h under low-stringency
conditions
(40°C). Positive plaques in primary screening were
subjected to
secondary screening using the same conditions. Following
the secondary
screening on the positive clones, in vivo excision
of the positive
phage isolates was performed to obtain the insert-containing
pBluescript phagemid as described in the manufacturer's
instruction.
Cloning and sequencing the full-length 100-kDa protein gene
(OmpW).
Based on primary sequence information obtained from the
original genomic library clones, genome-walking strategy (rapid
amplification of cDNA ends [RACE]) was employed to clone full-length
gene encoding 100-kDa protein using Universal GenomeWalker kit
(Clontech Laboratories, Palo Alto, Calif.). Reverse GSP and Forward GSP
oligonucleotide pairs were designed to obtain upstream and downstream
flanking sequences of the primary gene fragment, respectively (Table
1).
For DNA sequencing, plasmid DNA samples were prepared using Qiafilter
Plasmid Kit (Qiagen, Valencia, Calif.). DNA sequence
analysis was
performed at the University of California-Los Angeles
Sequencing
Facility using dideoxy dye termination PCR. Complete
coverage of entire
gene sequence and linkage of each contiguous
fragment were achieved by
subcloning and primer walking. Both
strands were completely sequenced
and assembled using the Wisconsin
Genetics Computer Group (GCG)
sequence analysis programs. The
OmpW sequence was characterized using
the BLASTX program (version
20.11, 20 January 2000) at National Center
for Biotechnology Information
and National Institutes of Health
nonredundant databases. The
analysis of amino acid sequence alignments
was performed using
ClustalW multiple-sequence alignment program at
EMBL Outstation
European Bioinformatics Institute and displayed by the
GenDoc
program (
www.psc.edu/biomed/genedoc).
OmpW-specific PCR.
To test ompW distribution in
enteric bacterial strains, PCR was performed on bacterial chromosomal
DNA samples to amplify an ompW-specific amplicon of 468 bp.
Chromosomal DNA was extracted from bacterial strains and used as the
templates in the PCR analysis with ompW-specific primers
(OmpW-f and OmpW-r) spanning nucleotides 893 to 1361 of the open
reading frame (Table 1). A phylogenetically conserved segment of the
bacterial 16S RNA was used to quantitate bacteria DNA sample in PCR
(16S primers, Table 1) (31). The PCRs were performed in a
50-µl volume consisting of 1 µg of genomic DNA, 0.5 U of
Taq polymerase, 2 mM deoxynucleotide triphosphate mixture,
and 1 µM each of primers in 1× PCR buffer using GeneAmp PCR System
9700 (PE Applied Biosystems): 5 min at 95°C followed by 30 cycles of
95°C for 60 s, 65°C for 60 s, and 72°C for 60 s.
After the final cycle, the reaction was extended at 72°C for 5 min
and cooled at 4°C.
Southern blot analysis.
Southern blot analysis was employed
to identify positive phages screened from genomic library and to
analyze ompW gene distribution in bacterial clinical
isolates. To identify insert-containing phagemids, digested
plasmid DNAs were electrophoresed on 0.8% agarose gel and depurinated
in 0.5 M HCl, denatured in 0.5 M Tris-Cl-1.5 M NaOH, and
neutralized in 0.5 M Tris-Cl-1.5 M NaCl buffer, and then transferred
onto Hybond N+ membrane (Amersham) by capillary blotting. After
blotting, the membranes were prehybridized for at least 1 h at
60°C in Rapid-Hyb buffer (Amersham Life Sciences) and hybridized at
60°C for 6 h in the same buffer with a mixture of
32P-labeled Pep1 and Pep2 oligonucleotide probes.
Membranes were washed for 15 min three times with 2× SSC containing
0.1% SDS at room temperature and then washed with 0.1× SSC containing
0.1% sodium dodecyl sulfate (SDS) at 60°C for 15 min three times.
Autoradiography was carried out at
70°C with intensifying screens
for an optimized exposure time on Hyper Film (Amersham Life Sciences).
To analyze the phylogeny of
ompW, chromosomal DNAs of
different bacterial strains were purified using GenomePrep DNA
isolation
kit (AmershamPharmacia); 5 µg of purified DNA samples were
digested
by
HindIII, electrophoresed, and transferred to
membranes. A 0.7-kb
insert in pBS 0.7 plasmid, which is located from
site 369 to site
1029 in full-length
ompW gene, was used as
the probe for hybridization
with restricted bacterial genomic DNAs. The
ompW-specific probe
was labeled with
32P by the random-primer method using Prime It II
system (Stratagene).
The hybridization was performed at 65°C in
Rapid-Hyb buffer for
3 to 6 h (Amersham Life Sciences). The
membranes were treated
as described above and exposed to Hyper Film at

70°C.
Expression of recombinant OmpW protein.
To express the OmpW
proteins, pairs of primers were designed to clone the full-length and
truncated OmpW open reading frame segments directly from p2Lc3 genome
by PCR. Forward primers used to amplify the full-length ORF (OmpW1) and
the OmpW2 and OmpW3 truncated proteins were designated OmpW 1f, 2f, and
3f, respectively. OmpW-R was used as the reverse primer for cloning
three segments (Table 1). In order to facilitate the construction of
expression vectors, a BamHI site was designed in the forward
primers and a SacI site in reverse primer for each fragment.
The PCR products were inserted in frame into His-taggged expression
vector pQE-30 (Qiagen). The full-length and truncated OmpW proteins
were expressed in E. coli XL-1 Blue strain as 6× His-tagged
proteins and purified by HisTrap column (AmershamPharmacia) under
denatured conditions according to manufacturer's instructions.
Western blot analysis.
The full-length and truncated
recombinant OmpW proteins were quantified using the Bradford assay
(Bio-Rad Laboratories, Hercules, Calif.), and equivalent protein
amounts (2 µg/well and 0.5 µg/well) were separated on 12%
polyacrylamide gels under reducing conditions. Electrophoresed proteins
were transferred overnight onto nitrocellulose membranes (Amersham Life
Sciences) in Tris-glycine buffer (National Diagnostics, Atlanta, Ga.)
and verified by Ponceau S red staining (Sigma Chemicals, St. Louis,
Mo.) or Coomassie blue staining. Membranes were blocked in 5% nonfat
milk (Carnation, Glendale, Calif.) in PBS with 0.1% Tween-20
(PBS-Tween) for 1 h. Fab 5-3 antibody diluted in 1%
milk-PBS-Tween was incubated with membranes for 1 h. Immunoblots
were detected by alkaline phosphatase-conjugated goat anti-human
F(ab)2 and developed with
5-bromo-4-chloro-3-indolylphosphate-nitro blue tetrazolium (BCIP/NBT)
liquid substrate system (Sigma Chemicals).
OmpW serum ELISA.
Human antibodies that bind OmpW were
detected by enzyme-linked immunosorbent assay (ELISA). Plates (USA
Scientific, Ocala, Fla.) were coated overnight at 4°C with 100 µl/well of OmpW recombinant protein at 5 µg/ml in borate-buffered
saline, pH 8.5. After three washes in 0.05% Tween 20 in PBS, the
plates were blocked with 150 µl/well of 0.5% bovine serum albumin in
PBS, pH 7.4 (BSA-PBS), for 30 min at room temperature (RT) and washed
again prior to incubation with sera. Then 100 µl/well of serum from
CD patients, UC patients and normal controls at various dilutions were
added in duplicate and incubated for 2 h at RT. The plates were
washed and incubated with alkaline phosphatase-conjugated goat
anti-human IgA or anti-human IgG (Jackson ImmunoResearch, West Grove,
Pa.) at a dilution of 1:1,000 in BSA-PBS for 2 h at RT. The plates were washed three times with 0.05% Tween 20 in PBS followed by another
three washes with Tris-buffered normal saline, pH 7.5. Substrate
solution (1.5 mg/ml of disodium P-nitrophenol phosphate; Amresco, Solon, Ohio) in 2.5 mM MgCl2-0.01 M
Tris, pH 8.6, was added at 100 µl/well to allow color development.
The absorbances were measured at 405 nm. Values for pANCA activity was
determined by neutrophil ELISA and categorized by neutrophil
immunofluorescence, as previously described (37).
Quantitative data were compared using the Mann-Whitney test. This
nonparametric statistic was selected because, with the relatively
small
sample size, Gaussian distribution of the group data sets
could not
be established. Contingency table data sets were analyzed
with
Fisher's exact test. This test was selected because it calculates
P values exactly and is a valid method for analyzing small
absolute
numbers of cells. Statistical analysis was performed with
Prism
3.0 (GraphPad Software, San Diego, Calif.).
Human subjects.
Serum samples from 69 subjects (23 each of
UC patients, CD patients, and healthy controls) were obtained from the
serum archive of the Cedars-Sinai IBD Research Center. Sera were
produced from standard phlebotomy blood specimens, anonymously number
coded, aliquoted, and stored at
80°C until use. The UC and CD
patient specimens were drawn from an ongoing genetic case-control
study; the demography, disease ascertainment methods, disease activity, and treatment profile of this population have been described previously (47, 51). At the time of our analysis, this study
contained 240 UC and 213 CD probands, respectively. Each patient was
diagnostically validated by clinical history, endoscopic and radiologic
examination, and histopathology findings.
Sera from this archive were selected by a simple concurrent control
method. Specimens accrued during 1999 were accessed, and
23 CD and UC
sera were chosen solely on the basis of maximum residual
volumes. Due
to the relatively small size of the specimen set
used in this study,
the data were not stratified for clinical
features (disease duration,
disease activity, and treatment profile).
Anti-OmpW levels were
measured in this study; the pANCA levels
of these sera were tabulated
from archive data. The latter data
revealed that the 23 UC and CD
specimens included 12 and 7 pANCA-positive
specimens, respectively.
Normal controls were from concurrent
blood bank donations with known
age, ethnicity, and blood
type.
Procedures for subject recruitment, informed consent, and specimen
procurement were in accordance with protocols approved
by the
Institutional Human Subject Protection Committees of UCLA
and
Cedars-Sinai Medical
Center.
Nucleotide sequence accession number.
The nucleotide
sequence data for the ompW gene of B. caccae
reported in this study have been assigned GenBank accession number AF305878.
 |
RESULTS |
Cloning of full-length gene encoding 100-kDa protein of
B. caccae.
The first goal of this study
was to clone the gene encoding 100-kDa protein of B. caccae. A genomic library of p2Lc3 was constructed by
ligating EcoRI-restricted chromosomal DNA into ZAPII phage vector. Two oligonucleotide probes were designed using
Bacteroides preferred codons from two N-terminal peptide
sequences (Pep1 and Pep2) of the tryptic 100-kDa protein
(8). To ensure a positive result in library
screening, a mixture of 32P-labeled Pep1 and Pep2
probes was used to hybridize with phage library under
low-stringency conditions (40°C). Approximately 106 phage plaques of the library were screened,
and eight positive clones were identified.
Following the secondary screening on the positive clones, in vivo
excision on the isolates was carried out, and three insert-containing
phagemids were obtained (designated 3-1, 3-2, and 5-2). The inserts
in
the three phagemids were 0.2 kb, 6.9 kb, and 7.2 kb. To further
localize the probe-identified sequence in the insert, restriction
enzyme-digested phagemids were hybridized with Pep1 and Pep2 probes
separately in Southern blot analysis. This revealed a 2-kb
AccI
fragment in 5-2 genomic clone which hybridized
strongly with the
Pep1 probe (Fig.
1).
Initial sequence analysis of the 2-kb fragment
and its flanking
sequence indicated that the insert in phagemid
5-2 was interrupted by a
1.2-kb Tn
10 transposon sequence. However,
PCR analysis of
p2Lc3 genomic DNA showed that this transposon
insertion was
absent in the
B. caccae genome and presumably was
the result of an artifactual transposon insertion during cloning
manipulation (data not shown).

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
Pep1 hybridization of a 2-kb AccI genomic
segment of B. caccae. Three clones (5-2, 3-2, and 1-1) were isolated from a primary screen of a genomic
B. caccae phage library. The clones were
digested with AccI, electrophoresed, transferred to
nitrocellulose membranes, and hybridized with the Pep1 or Pep2
oligonucleotide probe. (Left panel) Ethidium bromide-stained gel;
(middle panel) membrane hybridization with Pep1 oligonucleotide; (right
panel) membrane hybridization with Pep2 oligonucleotide.
|
|
In order to obtain authentic flanking sequences of 2-kb fragment, a
genome walking strategy was employed to clone full-length
ompW gene directly from the p2Lc3 genome. RACE cloning
produced
0.9-kb upstream and 1.3-kb downstream sequences flanking the
p2Lc3
2-kb fragment. In total, 4,034 bp were cloned and sequenced by
this
process.
Sequence analysis and structural features of deduced
OmpW protein.
The major cloning steps and the structural
features of the OmpW genomic segment are summarized in Fig.
2. The nucleotide sequence analysis of
4,034-bp p2Lc3 genomic fragment revealed a 2,844-bp-long open reading frame (ORF) encoding a putative outer membrane protein with a predicted molecular mass of 105 kDa and isoelectric point of
5.96. The Pep1 sequence was identified within this ORF. A 189-bp AT-rich region was identified upstream of the ORF (G+C content of 34%,
compared to 48% for the ompW ORF), perhaps representing a
promoter region. No homologies to known prokaryotic promoter sequences
were found in this putative ompW promoter region. However, this might reflect the structural divergence of regulatory elements in
Bacteroides compared to the more commonly characterized
E. coli elements (43).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Cloning of the ompW gene. A
genomic phage library of p2Lc3 was constructed and screened
using Pep1 and Pep2 probes. Southern analysis identified an authentic
Pep1-positive genomic clone, designated 5-2 (Fig. 1), which
contained an artifactual insert Tn10 sequence. The
native ompW gene was isolated by genome walking using
p2Lc3 genomic DNA as substrate. Sequence analysis of a 4,043-bp
fragment revealed an open reading frame encoding 947 amino acids and an
upstream AT-rich putative promoter locus.
|
|
Nucleic acid and amino acid homology analysis (BlastN and BlastX) of
the NCBI databases indicated that OmpW was homologous
to the outer
membrane proteins SusC of
Bacteroides thetaiotaomicron and
RagA of
Porphyromonas gingivalis (Fig.
3). The amino acid
similarity of OmpW was
comparable to SusC (identity, 30%; similarity,
47%) and RagA
(identity, 29%; similarity, 46%). The two regions
of greatest
similarity were located in the N-terminal 270 residues
and the extreme
C terminus.

View larger version (80K):
[in this window]
[in a new window]
|
FIG. 3.
Sequence homology of OmpW with SusC and Rag A outer
membrane proteins. The amino acid sequence of OmpW long open reading
frame is aligned with its two closest database homologues, SusC of
B. thetaiotaomicron and RagA of P.
gingivalis. The peptide 1 sequence, used as a cloning probe, is
also shown. Alignments were performed using the ClustalW
multiple-sequence alignment program and are displayed using the GenDoc
program. Residues with similarity (identical or conservative amino acid
changes) among all sequences are denoted by an uppercase letter, and
with single discordances by a lowercase letter or number. Gradations of
similarity frequency are denoted by dark to pale shading.
|
|
The deduced OmpW protein had features typical of bacterial
TonB-linked outer membrane proteins. A multiple sequence alignment
comparing OmpW with SusC, RagA, and outer TonB-linked receptors
for
iron acquisition or vitamin uptake from various bacterial
species is
shown in Fig.
4. The TonB box (amino
acids 160 to 193)
is highly conserved among TonB-dependent outer
membrane receptors
and is present in OmpW. Other more N-terminal (87 to
96, 109 to
113, and 126 to 131) clusters of homology were also
observed.
The C-terminal segment of OmpW also exhibits similarity to
TonB-dependent
receptor protein: a C-terminal phenylalanine residue and
the hydrophobic
amino acids at positions

3,

5,

7, and

9. The
same residues
are found in other TonB-linked outer membrane proteins
and are
thought to have important function in outer membrane protein
assembly
and sorting (
44,
46).

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 4.
OmpW contains a bacterial TonB box. Homologous sequences
of TonB-linked proteins from different bacterial species were
identified by BlastX and aligned and displayed as described in Fig. 3.
E.coli, E. coli; Porphyromo, P.
gingivalis; Bacteroide, Bacteroides fragilis;
Yersinia, Yersinia enterocolitica; Shigella,
Shigella dysenteriae; Haemophilu, Haemophilus
influenzae; Salmonella: Salmonella enterica
serovar Typhimurium; Helicobac, Helicobacter pylori;
Citrobacte, Citrobacter freundii; Pseudomona,
Pseudomonas sp; Synorhizob, Sinorhizobium
meliloti; Synechocys, Synechocystis sp;
Campylobac, Campylobacter jejuni. The TonB box is
labeled.
|
|
OmpW is specific to B. caccae.
To
determine the species selectivity of the OmpW, the distribution of the
ompW gene in different Bacteroides strains and
other gram-negative coliforms (E. coli, Salmonella enterica
serovar Typhi, and Shigella flexneri) was analyzed by PCR
and Southern blot. PCR was performed on chromosome DNAs of the enteric
bacterial strains (Fig. 5). The 468-bp
ompW-specific sequence was detectable in both available
B. caccae isolates, but was undetectable among four
Bacteroides species and eight isolates, and the E. coli, S. enterica serovar Typhi, and S. flexneri strains. In accord with PCR results, only B. caccae strains showed a strong hybridizing band by Southern
blot analysis, demonstrating that ompW is a B. caccae-specific gene (Fig. 6).
The result also indicated that the gene encoding 100-kDa protein
existed partially in a 10-kb HindIII restriction
fragment of the B. caccae genome as a single copy.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 5.
PCR detection of ompW distribution in
enteric bacteria. Chromosomal DNA samples from a panel of
Bacteroides strains and gram-negative coliforms
(E. coli, Salmonella enterica serovar Typhi,
Shigella flexneri) were detected by PCR for the
prevalence of ompW gene. The DNA samples were
quantitated by the detection of conserved bacterial 16S rRNA with 16S-f
and 16S-r primers (Table 1) in the same PCR. Negative control, no
template DNA; positive control, ompW plasmid clone.
|
|

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 6.
Southern blot analysis of ompW gene
distribution in bacterial genomic DNA. A total of 5 µg of the
HindIII-restricted bacterial genomic DNAs were
separated on 0.8% agarose gel and transferred onto nitrocellulose
membrane. The membranes were hybridized with a mixture of
32P-labeled ompW-specific fragment (0.7 kb)
and DNA markers under low-stringency conditions (40°C). The membranes
were exposed for an optimized time on Hyper Film. OmpW control, 10 pg
of ompW restriction fragment.
|
|
The Fab 5-3 pANCA monoclonal antibody recognizes the recombinant
OmpW protein.
To characterize the immunological properties of the
deduced OmpW protein, three gene fragments encoding full-length and
truncated OmpW proteins (as shown in Fig.
7A) were cloned directly from p2Lc3
genome by PCR and inserted in frame into pQE30, a His-tagged protein
expression vector. The OmpW1, OmpW2, and OmpW3 proteins (947, 805, and
648 amino acids, respectively) were purified by nickel chromatography,
separated on 12% acrylamide gel (Fig. 7B), and evaluated for
reactivity to the original Fab 5-3 pANCA monoclonal antibody by Western
blot analysis (Fig. 7C). It was indicated that Fab 5-3 recognized OmpW1
and OmpW2, but not OmpW3. These findings confirm that we had
cloned the intended Fab5-3 monoclonal antibody-pANCA-reactive
Bacteroides protein. They also suggest that the Fab5-3
monoclonal antibody-pANCA epitope is located towards the N terminus
of the protein, between amino acid positions 143 and 300.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 7.
Expression and analysis of full-length and truncated
OmpW proteins. (A) Strategy for expression of OmpW proteins. The gene
fragments encoding the full-length and truncated OmpW proteins were
cloned directly from p2Lc3. The OmpW-1 ORF starts from the first
putative start codon, located at site 1097 in the 4.34-kb cloned
fragment. OmpW-2 and OmpW-3 start from positions 1523 and 1994, respectively. The cloned OmpW segments were inserted into vector pQE30,
expressed as His-tagged recombinant proteins, and purified by nickel
chromatography. (B) SDS-PAGE analysis of purified recombinant OmpW
proteins. The purified recombinant OmpW proteins were separated at 2 µg/well and 0.5 µg/well on a 12% acrylamide gel and probed with
human pANCA antibody (Fab 5-3) in Western blot analysis. (C) Western
blot analysis of expressed OmpW proteins with Fab5-3 pANCA antibody.
The recombinant OmpW proteins were probed with Fab5-3 human monoclonal
antibody and then detected by alkaline phosphatase-conjugated
anti-human F(ab')2 and developed by NCIP/NBT substrate.
|
|
OmpW is an antigenic target in CD patients.
Purified
recombinant OmpW1 and OmpW2 proteins were used for ELISA
evaluation of human anti-OmpW antibody levels in human subjects (Fig.
8). The mean OD units of IgA
anti-OmpW were numerically elevated in the CD group (median,
0.168) compared to the UC (0.097) and normal (0.082) groups. Compared
to normals, this difference was significant for the CD group
(P < 0.002) but not the UC group. Similarly, the
frequency of positive seroreactivity was elevated in the CD group
(35%, 8 of 23), compared to the UC group (13%, 3 of 23) and normal
subjects (4%, 1 of 23). The frequency was significantly greater in the
CD versus normal group (P < 0.009); no significant
difference was observed between UC and normals (Fig. 8A). These
findings reflect an antibody response which is CD associated but of
moderate scale and expressed in a minority of CD patients.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 8.
Serum anti-OmpW antibody levels in normal and IBD
patients. ELISA wells coated with OmpW2 (A, B, D, E, and F) or OmpW1 (B
and C) were reacted with patient sera, and binding was detected by IgA-
(A, B, D, E, and F) or IgG- (C) specific secondary reagents and
expressed as absorbance units (OD405). Levels of pANCA
activity were expressed as enzyme units (EU) per milliliter. (A) Levels
of anti-OmpW2 IgA in normal, UC, and CD patients. Quantitative values
for each IBD group compared to normals were compared by a Mann-Whitney
(unpaired, two-tailed). Positive sera were defined as those exceeding
the mean + 2 standard deviations for the normal group (dashed line).
The frequencies of positive individuals in each IBD group compared to
normals were compared by a Fisher's exact test. (B) Levels of IgA
antibodies to OmpW1 and OmpW2. Correlation of the values was assessed
by linear regression. (C) Levels of anti-OmpW1 IgG in normal, UC, and
CD patients. Dashed line is the positive cutoff value, and solid lines
are the arithmetic means for each group. The standard deviations for
normal, UC, and CD values are: (A) 0.044, 0.026, and 0.87; (C) 0.45, 0.40, and 0.31. (D) Levels of anti-OmpW2 IgA in patients stratified for
UC-pANCA positive (+) and negative ( ) immunofluorescence. The
standard deviations are normal (0.044), UC+ (0.35), UC (0.089), CD+
(0.11), and CD (0.080). (E and F) Levels of IgA anti-OmpW2 and
pANCA in UC (E) and CD (F) patients. Patients were stratified for
UC-pANCA positive (solid symbols) and negative (open symbols)
immunofluorescence.
|
|
Since the Fab 5-3 antibody reacted with both the full-length and
truncated OmpW protein, we compared the levels of IgA anti-OmpW1
and
anti-OmpW2. As shown in Fig.
8B, these levels were highly
correlated by
linear regression (
r2 = 0.87,
P < 0.0001). In contrast to IgA, anti-OmpW2 IgG levels
were relatively high in both normal and IBD patients and were
not
significantly different between groups (Fig.
8C). The mechanism
and
significance of this isotype restriction remain to be
defined.
We further assessed whether IgA anti-OmpW2 was correlated with serum
pANCA activity. UC and CD patients were stratified for
pANCA positive
or negative status by immunofluorescence and DNase
antigen sensitivity
(
2,
37,
49) and compared for IgA anti-OmpW2
mean OD units
and seropositivity frequency (Fig.
8D). By both
criteria, pANCA status
did not correlate with anti-OmpW2 activity.
These patient groups were
further evaluated for the correlation
of quantitative levels of pANCA
and IgA anti-OmpW2 (Fig.
8E and
F). By linear regression, pANCA and
anti-OmpW2 were not significantly
correlated for either UC
(
r2 = 0.3,
P = 0.06) or CD patients (
r2 = 0.10,
P = 0.19). Most of the anti-OmpW-positive CD
patients
were pANCA negative. These findings indicate that
anti-OmpW is
CD associated but may reflect a distinct specificity
from the
predominant antineutrophil activity in UC
patients.
 |
DISCUSSION |
In this study, the B. caccae protein
identified by an IBD-associated pANCA monoclonal antibody was
characterized by molecular cloning and immunologic evaluation of the
recombinant gene product. The protein, termed OmpW, was found to be a
new member of the TonB-linked outer membrane protein family.
OmpW was also closely related to RagA, a virulence factor of
the periodontal disease pathogen P. gingivalis.
Evaluation of patient sera demonstrated increased
anti-OmpW IgA levels in CD patients. The issues raised by
this study are the relationship of OmpW to the outer membrane protein family, its relationship to candidate pANCA antigens, and
the role of OmpW and B. caccae in IBD pathogenesis.
Identification of the 100-kDa antigen.
OmpW was cloned from a
B. caccae genomic library probed with
oligonucleotide derived from 100-kDa tryptic peptide sequences. OmpW
corresponds to the 100-kDa antigen by several criteria. First, the
predicted molecular mass was 105 kDa, and this size was confirmed by
SDS-PAGE analysis of recombinantly expressed OmpW. Second, the
recombinant protein was immunoreactive with the 5-3 pANCA monoclonal
antibody. Third, OmpW was encoded by a single-copy gene and was
detected exclusively in B. caccae (versus other
species of Bacteroides and various gram-negative coliforms).
These findings agree with the size and species distribution of the
100-kDa protein, as originally defined using Western analysis of
colonic bacterial species with the 5-3 pANCA monoclonal antibody
(8).
Relationship to TonB-linked outer membrane protein family.
The
OmpW protein sequence was notable for the presence of a TonB box and
other clusters of homology with TonB-linked receptors. The TonB complex
is an energy transduction system which powers high-affinity active
transport of certain membrane receptors across the gram-negative outer
membrane (7, 25). The TonB box is a conserved domain of
TonB-linked outer membrane proteins, mediating their association
with the TonB complex. In Enterobacteriaceae, this
system plays an important role in iron acquisition (siderophore transport), necessary for growth in iron-limited environments, including host cell tissues (23, 25).
The OmpW protein had extensive overall homology with SusC and RagA.
SusC protein is an essential receptor for uptake and utilization
of certain starches and intermediate-sized maltooligosaccharides,
apparently powered by a
Bacteroides homologue of the TonB
complex
(
28,
29). With respect to RagA, the
ragAB locus has been validated
as a virulence factor of
P. gingivalis tissue damage and in vivo
survival, and RagA
and RagB are recognized targets of disease-associated
periodontal
antibody responses (
11,
21,
22). On this basis,
RagA is
implicated in
P. gingivalis-associated periodontal disease.
As an analogue of both SusC and RagA, OmpW may potentially play
similar
roles in facilitating uptake of substrates important to
commensal
intestinal survival and as the target of tissue-destructive
immune
responses in susceptible hosts. Such a potential role makes
it
important to further assess the distribution of OmpW in other
members
of the
Bacteroides-Porphyromonas-Prevotella group.
Relationship of OmpW to other pANCA antigens.
A number of
bacterial and mammalian proteins have been advanced as candidate pANCA
antigens. The OmpW epitope recognized by the 5-3 pANCA monoclonal
antibody was localized by truncation mutants. Thus, antigenicity was
lost by the truncation from OmpW2 to OmpW3 (residues 143 to 300). This
is the unique segment of OmpW bearing KKAK motifs, which were
previously identified as core epitopes in three other candidate
pANCA antigens (mammalian histone H1, HMG1/2, and mycobacterial
HupB) (9, 16). In contrast, other candidate pANCA
antigens lack the KKAK motif (E. coli OmpC).
The present study also demonstrates that anti-OmpW IgA does not
correlate with pANCA seroreactivity in human IBD patients.
The Fab 5-3 pANCA monoclonal antibody was selected in the bacterial
antigen search
because it represents one of only two pANCA monoclonal
antibodies
reported in the literature. The other antibody, Fab
5-2, was
nonreactive with OmpW, perhaps due to its sensitivity
to denaturation
of its cognate epitope (
8). Individual monoclonal
antibodies may not reflect the predominant epitopes detected by
an
antibody response. This issue may account for the discordance
between
OmpW and the predominant antigen(s) detected by pANCA
serum antibodies
(
8). Specifically, our observations indicate
that
antibodies specific for the KKAK motif are a minor component
of the
serum pANCA repertoire. This supports the emerging view
that
IBD-associated pANCA immunoreactivity involves not one but
several
peptide motifs and conformational determinants (
8).
The immunologic stimulus leading to this divergent ensemble of
immunoreactivities is uncertain but is reminiscent of epitope
spreading observed in other chronic antimicrobial and autoreactive
immune responses (
42). It may be instructive to evaluate
the
association of anti-OmpW activity with stratified patient
subpopulations.
This issue will require a much larger patient study
design, to
accrue sufficient numbers of subjects to analyze in a
statistically
meaningful way for patient subgroups with distinct
clinical features
(disease duration, disease activity, and treatment
profile).
Bacteroides, OmpW, and IBD pathogenesis.
The
immunologic finding in this paper is that there was an elevation of
anti-OmpW IgA levels in a subset of patients with CD (compared to
healthy controls and UC patients). The number of subjects in the
present study was insufficient to address the potential correlation of
anti-OmpW IgA with clinically or genetically defined CD patient
subpopulations. A larger population study and alternate randomization
strategies may also resolve potential type 1 statistical error in our
conclusions regarding disease association. The immunoreactivity might
be secondary to mucosal damage and increased bacterial antigen delivery
across the disrupted epithelial barrier to inductive immunologic sites.
In support of this idea, Bacteroides spp. (including
B. caccae) are a major component of the colonic
microflora and typically display a commensal, nonvirulent phenotype
(19). Monoassociation studies have implicated Bacteroides vulgatus as a pathogenic factor in a rat
transgenic model of colitis (27). CD is distinguished not
only by antibody immunoreactivity to several colonic bacterial taxa
(1, 3, 50), but also by a striking expansion of T cells
reactive to autologous colonic bacteria, including B. thetaiotaomicron (14). Gut-associated T lymphocytes
are remarkably anergic to colonic bacterial antigens. Similar
observations have been made in mouse models of IBD, notably the
capacity of such T cells to establish disease by cell transfer
(10). These observations strongly implicate immune
responses to one or more enteric bacterial species as an important
element of mucosal damage in IBD. The present work provides specific
bacterial species and protein antigens for experimental evaluation.
How commensal bacteria become harmful in a susceptible host remains to
be elucidated. Overgrowth of enteric bacteria is observed
in IBD
patients, indicating that IBD involves disruption of the
normal enteric
bacterial ecosystem, caused by or resulting in
host immune and
inflammatory responses. It is conceivable that
factors related to
bacterial growth may play a role in this ecosystem
disruption.
Competition for scarce nutrients, notably iron, directly
shapes the
dynamics of bacterial populations (
19). Moreover,
transcriptional control of virulence traits is a common feature
of
signaling pathways regulated by uptake of such nutrients and
quorum-sensing mechanisms (
12,
24). In this context,
TonB-linked
proteins such as
B. caccae OmpW may
play a significant role in
such
processes.
Little is presently known about the prevalence and distribution of
B. caccae in the intestine of healthy persons or
IBD patients,
its targeting by the disease-related immune response, and
role
in IBD pathogenesis evaluated through monoassociation study of
bacterial virulence in IBD. The present study points to
B. caccae and OmpW for such experimental evaluation in IBD
pathogenesis.
 |
ACKNOWLEDGMENTS |
We are especially grateful for the technical assistance of
Kathleen Lechowitzc and Kevin Ward. We thank Dominica Salvatore for
assistance in preparation of the manuscript.
This work was supported by NIH grants DK46763 (J.B., S.R.T.), DK43026
(S.R.T.), and AI 07126-23 (H.D., the UCLA Clinical and Fundamental
Immunology Training Grant), the Crohn's and Colitis Foundation of
America (W.B.), the Jonsson Comprehensive Cancer Center
(J.B.), CURE Digestive Diseases Research Center (J.B.), and the
Feintech Family Chair of Inflammatory Bowel Disease (S.R.T.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology and Lab Medicine, UCLA School of Medicine, CHS 13-222, Los Angeles, CA 90095-1732. Phone: (310) 794-7953. Fax: (310) 825-5674. E-mail: jbraun{at}mednet.ucla.edu.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Auer, I. O.,
A. Roder,
F. J. Wensinck,
P. van de Merwe, and H. Schmidt.
1983.
Selected bacterial antibodies in Crohn's disease and ulcerative colitis.
Scand. J. Gastroenterol.
18:217-223[Medline].
|
| 2.
|
Billing, P.,
S. Tahir,
B. Calfin,
G. Gagne,
L. Cobb,
S. R. Targan, and A. Vidrich.
1995.
Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies.
Am. J. Pathol.
147:979-987[Abstract].
|
| 3.
|
Blaser, M. J.,
R. A. Miller,
J. Lacher, and J. W. Singleton.
1984.
Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens.
Gastroenterology
87:888-894[Medline].
|
| 4.
|
Blumberg, R. S.,
L. J. Saubermann, and W. Strober.
1999.
Animal models of mucosal inflammation and their relation to human inflammatory bowel disease.
Curr. Opin. Immunol.
11:648-656[CrossRef][Medline].
|
| 5.
|
Boismenu, R., and Y. Chen.
2000.
Insights from mouse models of colitis.
J. Leukocyte Biol.
67:267-278[Abstract].
|
| 6.
|
Brandwein, S. L.,
R. P. McCabe,
Y. Cong,
K. B. Waites,
B. U. Ridwan,
P. A. Dean,
T. Ohkusa,
E. H. Birkenmeier,
J. P. Sundberg, and C. O. Elson.
1997.
Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora.
J. Immunol.
159:44-52[Abstract].
|
| 7.
|
Braun, V.,
S. Gaisser,
C. Herrmann,
K. Kampfenkel,
H. Killmann, and I. Traub.
1996.
Energy-coupled transport across the outer membrane of Escherichia coli: ExbB binds ExbD and TonB in vitro, and leucine 132 in the periplasmic region and aspartate 25 in the transmembrane region are important for ExbD activity.
J. Bacteriol.
178:2836-2845[Abstract/Free Full Text].
|
| 8.
|
Cohavy, O.,
D. Bruckner,
L. K. Gordon,
R. Misra,
B. Wei,
M. E. Eggena,
S. R. Targan, and J. Braun.
2000.
Colonic bacteria express an ulcerative colitis pANCA-related protein epitope.
Infect. Immun.
68:1542-1548[Abstract/Free Full Text].
|
| 9.
|
Cohavy, O.,
G. Harth,
M. A. Horwitz,
C. Landers,
C. Sutton,
S. R. Targan, and J. Braun.
1999.
Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum IgA from patients with Crohn's disease.
Infect. Immun
67:6510-6517[Abstract/Free Full Text].
|
| 10.
|
Cong, Y. Z.,
S. L. Brandwein,
R. P. McCabe,
A. Lazenby,
E. H. Birkenmeier,
J. P. Sundberg, and C. O. Elson.
1998.
CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease.
J. Exp. Med.
187:855-864[Abstract/Free Full Text].
|
| 11.
|
Curtis, M. A.,
S. A. Hanley, and J. Aduse-Opoku.
1999.
The rag locus of Porphyromonas gingivalis: a novel pathogenicity island.
J. Periodont. Res.
34:400-405[CrossRef][Medline].
|
| 12.
|
de Kievit, T. R., and B. H. Iglewski.
2000.
Bacterial quorum sensing in pathogenic relationships.
Infect. Immun.
68:4839-4849[Free Full Text].
|
| 13.
|
Dianda, L.,
A. M. Hanby,
N. A. Wright,
A. Sebesteny,
A. C. Hayday, and M. J. Owen.
1997.
T cell receptor-alpha, beta-deficient mice fail to develop colitis in the absence of a microbial environment.
Am. J. Pathol.
150:91-97[Abstract].
|
| 14.
|
Duchmann, R.,
E. May,
M. Heike,
P. Knolle,
M. Neurath, and B. K. Zum.
1999.
T cell specificity and cross reactivity towards enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans.
Gut
44:812-818[Abstract/Free Full Text].
|
| 15.
|
Duerr, R. H.,
S. R. Targan,
C. J. Landers,
L. R. Sutherland, and F. Shanahan.
1991.
Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses.
Gastroenterology
100:1590-1596[Medline].
|
| 16.
|
Eggena, M.,
O. Cohavy,
M. Parseghian,
B. A. Hamkalo,
D. Clemens,
S. R. Targan,
L. K. Gordon, and J. Braun.
2000.
Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA.
J. Autoimmunity
14:83-97[CrossRef][Medline].
|
| 17.
|
Eggena, M.,
S. R. Targan,
L. Iwanczyk,
A. Vidrich,
L. K. Gordon, and J. Braun.
1996.
Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis.
J. Immunol
156:4005-4011[Abstract].
|
| 18.
|
Elson, C. O.,
R. B. Sartor,
G. S. Tennyson, and R. H. Riddell.
1995.
Experimental models of inflammatory bowel disease.
Gastroenterology
109:1344-1367[CrossRef][Medline].
|
| 19.
|
Finegold, S. M., and V. L. Sutter.
1978.
Fecal flora in different populations, with special reference to diet.
Am. J. Clin. Nutr.
1:S116-S122.
|
| 20.
|
Hammer, R. E.,
S. D. Maika,
J. A. Richardson,
J. P. Tang, and J. D. Taurog.
1990.
Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta2m: an animal model of HLA-B27-associated human disorders.
Cell
63:1099-1112[CrossRef][Medline].
|
| 21.
|
Hanley, S. A.,
J. Aduse-Opoku, and M. A. Curtis.
1999.
A 55-kilodalton immunodominant antigen of Porphyromonas gingivalis W50 has arisen via horizontal gene transfer.
Infect. Immun.
67:1157-1171[Abstract/Free Full Text].
|
| 22.
|
Kojima, T.,
K. Yano, and I. Ishikawa.
1997.
Relationship between serum antibody levels and subgingival colonization of Porphyromonas gingivalis in patients with various types of periodontitis.
J. Periodontol.
68:618-625[Medline].
|
| 23.
|
Larsen, R. A.,
P. S. Myers,
J. T. Skare,
C. L. Seachord,
R. P. Darveau, and K. Postle.
1996.
Identification of TonB homologs in the family Enterobacteriaceae and evidence for conservation of TonB-dependent energy transduction complexes.
J. Bacteriol.
178:1363-1373[Abstract/Free Full Text].
|
| 24.
|
Litwin, C. M., and S. B. Calderwood.
1993.
Role of iron in regulation of virulence genes.
Clin. Microbiol. Rev.
6:137-149[Abstract/Free Full Text].
|
| 25.
|
Moeck, G. S., and J. W. Coulton.
1998.
TonB-dependent iron acquisition: mechanisms of siderophore-mediated active transport.
Mol. Microbiol.
28:675-681[CrossRef][Medline].
|
| 26.
|
Panwala, C. M.,
J. C. Jones, and J. L. Viney.
1998.
A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis.
J. Immunol.
161:5733-5744[Abstract/Free Full Text].
|
| 27.
|
Rath, H. C.,
H. H. Herfarth,
J. S. Ikeda,
W. B. Grenther,
T. E. Jr. Hamm,
E. Balish,
J. D. Taurog,
R. E. Hammer,
K. H. Wilson, and R. B. Sartor.
1996.
Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.
J. Clin. Investig.
98:945-953[Medline].
|
| 28.
|
Reeves, A. R.,
J. N. D'Elia,
J. Frias, and A. A. Salyers.
1996.
A Bacteroides thetaiotaomicron outer membrane protein that is essential for utilization of maltooligosaccharides and starch.
J. Bacteriol.
178:823-830[Abstract/Free Full Text].
|
| 29.
|
Reeves, A. R.,
G. R. Wang, and A. A. Salyers.
1997.
Characterization of four outer membrane proteins that play a role in utilization of starch by Bacteroides thetaiotaomicron.
J. Bacteriol.
179:643-649[Abstract/Free Full Text].
|
| 30.
|
Reumaux, D.,
C. Meziere,
J.-F. Colombel,
P. Duthilleul, and S. Muller.
1995.
Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease.
Clin. Immunol. Immunopathol.
77:349-357[CrossRef][Medline].
|
| 31.
|
Rolleke, S.,
G. Muyzer,
C. Wawer,
G. Wanner, and W. Lubitz.
1996.
Identification of bacteria in a biodegraded wall painting by denaturing gradient gel electrophoresis of PCR-amplified gene fragments coding for 16S rRNA.
Appl. Environ. Microbiol.
62:2059-2065[Abstract].
|
| 32.
|
Rudolph, U.,
M. J. Finegold,
S. S. Rich,
G. R. Harriman,
Y. Srinivasan,
P. Brabet,
A. Bradley, and L. Birnbaumer.
1995.
Gi2 alpha protein deficiency: a model of inflammatory bowel disease.
J. Clin. Immunol.
15:101.S-105S[CrossRef][Medline].
|
| 33.
|
Rutgeerts, P.,
M. Hiele,
K. Geboes,
M. Peeters,
R. Aerts, and R. Kerremans.
1995.
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.
Gastroenterology
108:1617-1621[CrossRef][Medline].
|
| 34.
|
Sartor, R. B.
1995.
Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Gastroenterol. Clin. North Am
24:475-507[Medline].
|
| 35.
|
Sartor, R. B.
1997.
Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
Am. J. Gastroenterol.
92:5.S-11S[Medline].
|
| 36.
|
Satsangi, J.,
C. J. Landers,
K. I. Welsh,
K. Koss,
S. R. Targan, and D. P. Jewell.
1998.
The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease.
Inflamm. Bowel Dis.
4:18-26[Medline].
|
| 37.
|
Saxon, A.,
F. Shanahan,
C. Landers,
T. Ganz, and S. R. Targan.
1990.
A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease.
J. Allergy Clin. Immunol.
86:202-210[CrossRef][Medline].
|
| 38.
|
Schwartz, R. D., and S. K. Datta.
1989.
Autoimmunity and autoimmune diseases, p. 819-866.
In
W. E. Paul (ed.), Fundamental immunology. Raven Press, New York, N.Y.
|
| 39.
|
Seibold, F.,
S. Brandwein,
S. Simpson,
C. Terhorst, and C. O. Elson.
1998.
pANCA represents a cross-reactivity to enteric bacterial antigens.
J. Clin. Immunol.
18:153-160[CrossRef][Medline].
|
| 40.
|
Sellon, R. K.,
S. Tonkonogy,
M. Schultz,
L. A. Dieleman,
W. Grenther,
E. Balish,
D. M. Rennick, and R. B. Sartor.
1998.
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.
Infect. Immun.
66:5224-5231[Abstract/Free Full Text].
|
| 41.
|
Shanahan, F.,
R. H. Duerr,
J. I. Rotter,
H.-Y. Yang,
L. R. Sutherland,
C. McElree,
C. J. Landers, and S. R. Targan.
1992.
Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity.
Gastroenterology
103:456-461[Medline].
|
| 42.
|
Shastri, N.,
A. Oki,
A. Miller, and E. E. Sercarz.
1985.
Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins.
J. Exp. Med.
162:332-345[Abstract/Free Full Text].
|
| 43.
|
Smith, C. J.
1985.
Development and use of cloning systems for Bacteroides fragilis: cloning of a plasmid-encoded clindamycin resistance determinant.
J. Bacteriol.
164:294-301[Abstract/Free Full Text].
|
| 44.
|
Struyve, M.,
M. Moons, and J. Tommassen.
1991.
Carboxy-terminal phenylalanine is essential for the correct assembly of a bacterial outer membrane protein.
J. Mol. Biol.
218:141-148[CrossRef][Medline].
|
| 45.
|
Tan, E. M.
1991.
Autoantibodies in pathology and cell biology.
Cell
67:841-842[CrossRef][Medline].
|
| 46.
|
Tommassen, J.,
M. Struyve, and H. de Cock.
1992.
Export and assembly of bacterial outer membrane proteins.
Antonie Van Leeuwenhoek
61:81-85[CrossRef][Medline].
|
| 47.
|
Toyoda, H.,
S.-J. Wang,
H.-Y. Yang,
A. Redford,
D. Magalong,
D. Tyan,
C. McElree,
S. Pressman,
F. Shanahan,
S. R. Targan, and J. I. Rotter.
1993.
Distinct associations of HLA class II genes with inflammatory bowel disease.
Gastroenterology
104:741-748[Medline].
|
| 48.
|
van J. P. de Merwe,
A. M. Schroder,
F. Wensinck, and M. P. Hazenberg.
1988.
The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives.
Scandinavian J. Gastroenterology
23:1125-1131[Medline].
|
| 49.
|
Vidrich, A.,
J. Lee,
E. James,
L. Cobb, and S. R. Targan.
1995.
Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
J. Clin. Immunol.
15:293-299[CrossRef][Medline].
|
| 50.
|
Wayne, L. G.,
D. Hollander,
B. Anderson,
H. A. Sramek,
C. M. Vadheim, and J. I. Rotter.
1992.
Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives.
J. Clin. Microbiol.
30:2013-2018[Abstract/Free Full Text].
|
| 51.
|
Yang, H.-Y.,
J. I. Rotter,
H. Toyoda,
C. Landers,
D. Tyan,
C. K. McElree, and S. R. Targan.
1993.
Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
J. Clin. Investig.
92:1080-1084.
|
Infection and Immunity, October 2001, p. 6044-6054, Vol. 69, No. 10
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6044-6054.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Furrie, E, Macfarlane, S, Cummings, J H, Macfarlane, G T
(2004). Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut
53: 91-98
[Abstract]
[Full Text]